Histogen Inc. Common Stock
HSTO
HSTO was delisted on the 4th of October, 2023.
36 hedge funds and large institutions have $1.38M invested in Histogen Inc. Common Stock in 2019 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 5 increasing their positions, 15 reducing their positions, and 14 closing their positions.
244% more call options, than puts
Call options by funds: $62K | Put options by funds: $18K
14% less funds holding
Funds holding: 42 → 36 (-6)
43% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 14
67% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 15
85% less capital invested
Capital invested by funds: $9.15M → $1.38M (-$7.77M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$194K |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
+$193K |
| 3 |
VF
Virtu Financial
New York
|
+$82.3K |
| 4 |
KM
Kalos Management
Alpharetta,
Georgia
|
+$41.3K |
| 5 |
Wolverine Trading
Chicago,
Illinois
|
+$23.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MAM
MPM Asset Management
Boston,
Massachusetts
|
-$2.66M |
| 2 |
HP
Hikari Power
Tokyo,
Japan
|
-$217K |
| 3 |
Parallax Volatility Advisers
San Francisco,
California
|
-$206K |
| 4 |
QI
QS Investors
New York
|
-$105K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$86.8K |
HSTO Hedge Fund Activity: Q2 2019 in Review
36 of the 4,625 institutional investors tracked by Wall St. Rank reported a position in Histogen Inc. Common Stock (HSTO) for Q2 2019, worth a combined $1.38M — down 85% from $9.15M a quarter earlier.
Sellers outnumbered buyers: 14 funds closed out of HSTO and 8 opened new positions — a net loss of 6 holders — while 15 trimmed existing stakes and 5 added.
The largest buyer was Vanguard Group, adding an estimated $194K. The largest seller was MPM Asset Management, exiting entirely with an estimated $2.66M sold.
- 36 institutional investors held Histogen Inc. Common Stock (HSTO) as of Q2 2019, down from 42 in Q1 2019.
- Funds reported $1.38M of Histogen Inc. Common Stock stock for Q2 2019, down 85% quarter-over-quarter.
- 8 funds opened new Histogen Inc. Common Stock positions in Q2 2019 and 14 closed out, a net change of -6 holders.
- The largest Histogen Inc. Common Stock buyer in Q2 2019 was Vanguard Group, an estimated $194K added.
- The largest Histogen Inc. Common Stock seller in Q2 2019 was MPM Asset Management, an estimated $2.66M sold.
Based on aggregated 13F filings for Q2 2019.